AZTA
Azenta Inc
NASDAQ · Life Sciences Tools & Services
$28.72
+0.87 (+3.12%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 597.02M | 583.89M | 185.41M | 187.37M | 144.31M |
| Net Income | -56,061,296 | -49,344,906 | 26.25M | 32.22M | 21.04M |
| EPS | — | — | — | — | — |
| Profit Margin | -9.4% | -8.9% | 14.2% | 17.2% | 14.6% |
| Rev Growth | +2.3% | +2.3% | +14.1% | +14.4% | +24.6% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 593.8K | 593.8K | 287.47M | 264.21M | 312.50M |
| Total Equity | 659.82M | 659.82M | 952.65M | 881.10M | 1.03B |
| D/E Ratio | 0.00 | 0.00 | 0.30 | 0.30 | 0.30 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 35.48M | 32.96M | 35.92M | 41.07M | 26.80M |
| Free Cash Flow | — | — | 19.26M | 23.15M | 17.97M |